Financial updates
Pharming announces cashless warrant exercises and conversions of its Ordinary Bonds into shares
Pharming Group N.V. today announced that since the release of its 2017 Half Year Report on 27 July 2017, it has issued 12,053,268 new shares to holders of warrants who have exercised those warrants, and to holders of its ordinary convertible bonds due 2021 who have converted their Bonds into shares.